1. Home
  2. AADI vs HOLO Comparison

AADI vs HOLO Comparison

Compare AADI & HOLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AADI
  • HOLO
  • Stock Information
  • Founded
  • AADI 2011
  • HOLO 2018
  • Country
  • AADI United States
  • HOLO China
  • Employees
  • AADI N/A
  • HOLO N/A
  • Industry
  • AADI Biotechnology: Pharmaceutical Preparations
  • HOLO Computer Software: Programming Data Processing
  • Sector
  • AADI Health Care
  • HOLO Technology
  • Exchange
  • AADI Nasdaq
  • HOLO Nasdaq
  • Market Cap
  • AADI 59.4M
  • HOLO 50.1M
  • IPO Year
  • AADI N/A
  • HOLO N/A
  • Fundamental
  • Price
  • AADI $2.34
  • HOLO $1.33
  • Analyst Decision
  • AADI Hold
  • HOLO
  • Analyst Count
  • AADI 3
  • HOLO 0
  • Target Price
  • AADI $1.75
  • HOLO N/A
  • AVG Volume (30 Days)
  • AADI 109.6K
  • HOLO 3.8M
  • Earning Date
  • AADI 11-06-2024
  • HOLO 02-08-2025
  • Dividend Yield
  • AADI N/A
  • HOLO N/A
  • EPS Growth
  • AADI N/A
  • HOLO N/A
  • EPS
  • AADI N/A
  • HOLO N/A
  • Revenue
  • AADI $25,070,000.00
  • HOLO $32,242,196.00
  • Revenue This Year
  • AADI $9.39
  • HOLO N/A
  • Revenue Next Year
  • AADI $6.15
  • HOLO N/A
  • P/E Ratio
  • AADI N/A
  • HOLO N/A
  • Revenue Growth
  • AADI 7.80
  • HOLO 326.95
  • 52 Week Low
  • AADI $1.21
  • HOLO $1.28
  • 52 Week High
  • AADI $2.63
  • HOLO $1,968.00
  • Technical
  • Relative Strength Index (RSI)
  • AADI 58.75
  • HOLO 26.60
  • Support Level
  • AADI $2.25
  • HOLO $1.28
  • Resistance Level
  • AADI $2.45
  • HOLO $1.60
  • Average True Range (ATR)
  • AADI 0.11
  • HOLO 0.16
  • MACD
  • AADI -0.01
  • HOLO 0.03
  • Stochastic Oscillator
  • AADI 39.89
  • HOLO 2.75

About AADI Aadi Bioscience Inc.

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

About HOLO MicroCloud Hologram Inc.

MicroCloud Hologram Inc, through its subsidiaries, is mainly engaged in holographic Technology. It includes Holographic solutions and Holographic technology services. The company also provides holographic digital twin technology services for customers and has built a holographic digital twin technology resource library.

Share on Social Networks: